Bifidobacterium longum subsp infantis (EVC001) is associated with reduced incidence of necrotizing enterocolitis stage ≥2 and bloody stools in premature babies

Underwood MA, Mukhopadhyay S, Lakshminrusimha S, Bevins CL. Neonatal intestinal dysbiosis. J Perinatol. 2020;40:1597–608.

Article  PubMed  PubMed Central  Google Scholar 

Wurm P, Stampfer L, Greimel T, Leitner E, Zechner EL, Bauchinger S, et al. Gut microbiota dysbiosis in suspected food protein induced proctocolitis-a prospective comparative cohort trial. J Pediatr Gastroenterol Nutr. 2023;77:31–38.

Article  CAS  PubMed  Google Scholar 

Mai V, Young CM, Ukhanova M, Wang X, Sun Y, Casella G, et al. J. Fecal microbiota in premature infants prior to necrotizing enterocolitis. PLoS One. 2011;6:e20647.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Torrazza RM, Ukhanova M, Wang X, Sharma R, Hudak ML, Neu J, et al. Intestinal microbial ecology and environmental factors affecting necrotizing enterocolitis. PLoS One. 2013;8:e83304.

Article  PubMed  PubMed Central  Google Scholar 

Pammi M, Cope J, Tarr PI, Warner BB, Morrow AL, Mai V, et al. Intestinal dysbiosis in preterm infants preceding necrotizing enterocolitis: a systematic review and meta-analysis. Microbiome 2017;5:31.

Article  PubMed  PubMed Central  Google Scholar 

Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am. 1986;33:179–201.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jones IH, Hall NJ. Contemporary outcomes for infants with necrotizing enterocolitis-a systematic review. J Pediatr. 2020;220:86–92.e3.

Article  PubMed  Google Scholar 

Bazacliu C, Neu J. Necrotizing enterocolitis: long term complications. Curr Pediatr Rev. 2019;15:115–24.

Article  PubMed  Google Scholar 

Wang Y, Hang C, Hu J, Li C, Zhan C, Pan J, et al. Role of gut-brain axis in neurodevelopmental impairment of necrotizing enterocolitis. Front Neurosci. 2023;17:1059552.

Article  PubMed  PubMed Central  Google Scholar 

Matei A, Montalva L, Goodbaum A, Lauriti G, Zani A. Neurodevelopmental impairment in necrotising enterocolitis survivors: systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2020;105:432–9.

Article  PubMed  Google Scholar 

Zozaya C, Shah J, Pierro A, Zani A, Synnes A, Lee S, et al. Canadian Neonatal Network (CNN) and the Canadian Neonatal Follow-Up Network (CNFUN) Investigators. Neurodevelopmental and growth outcomes of extremely preterm infants with necrotizing enterocolitis or spontaneous intestinal perforation. J Pediatr Surg. 2021;56:309–16.

Article  PubMed  Google Scholar 

Mondal A, Misra D, Al-Jabir A, Hubail D, Ward T, Patel B. Necrotizing enterocolitis in neonates: has the brain taken a hit 10 years later? J Pediatr Neurosci. 2021;16:30–34.

Article  PubMed  PubMed Central  Google Scholar 

Canvasser J, Patel RM, Pryor E, Green L, Hintz SR, Fagan M, et al. Long-term outcomes and life-impacts of necrotizing enterocolitis: A survey of survivors and parents. Semin Perinatol. 2023;47:151696.

Article  PubMed  Google Scholar 

Kim JH, An HJ, Garrido D, German JB, Lebrilla CB, Mills DA. Proteomic analysis of Bifidobacterium longum subsp. infantis reveals the metabolic insight on consumption of prebiotics and host glycans. PLoS One. 2013;8:e57535.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Meng D, Sommella E, Salviati E, Campiglia P, Ganguli K, Djebali K, et al. Indole-3-lactic acid, a metabolite of tryptophan, secreted by Bifidobacterium longum subspecies infantis is anti-inflammatory in the immature intestine. Pediatr Res. 2020;88:209–17.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ehrlich AM, Pacheco AR, Henrick BM, Taft D, Xu G, Huda MN, et al. Indole-3-lactic acid associated with Bifidobacterium-dominated microbiota significantly decreases inflammation in intestinal epithelial cells. BMC Microbiol. 2020;20:357.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Samara J, Moossavi S, Alshaikh B, Ortega VA, Pettersen VK, Ferdous T, et al. Supplementation with a probiotic mixture accelerates gut microbiome maturation and reduces intestinal inflammation in extremely preterm infants. Cell Host Microbe. 2022;30:696–711.

Article  CAS  PubMed  Google Scholar 

Batta VK, Rao SC, Patole SK. Bifidobacterium infantis as a probiotic in preterm infants: a systematic review and meta-analysis. Pediatr Res 2023;94:1887–905. https://doi.org/10.1038/s41390-023-02716-w.

Article  PubMed  PubMed Central  Google Scholar 

Taft DH, Lewis ZT, Nguyen N, Ho S, Masarweh C, Dunne-Castagna V, et al. Bifidobacteriumspecies colonization in infancy: a global cross-sectional comparison by population history of breastfeeding. Nutrients. 2022;14:1423.

Article  PubMed  PubMed Central  Google Scholar 

Duar RM, Casaburi G, Mitchell RD, Scofield LNC, Ortega Ramirez CA, Barile D, et al. Comparative genome analysis of Bifidobacterium longum subsp. infantis strains reveals variation in human milk oligosaccharide utilization genes among commercial probiotics. Nutrients. 2020;12:3247.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Smilowitz JT, Moya J, Breck MA, Cook C, Fineberg A, Angkustsiri K, et al. Safety and tolerability of Bifidobacterium longum subspecies infantis EVC001 supplementation in healthy term breastfed infants: a phase I clinical trial. BMC Pediatr. 2017;17:133.

Article  PubMed  PubMed Central  Google Scholar 

Bajorek S, Duar RM, Corrigan M, Matrone C, Winn KA, Norman S, et al. B. infantis EVC001 is well-tolerated and improves human milk oligosaccharide utilization in preterm infants in the neonatal intensive care unit. Front Pediatr. 2022;9:795970.

Article  PubMed  PubMed Central  Google Scholar 

Tobias J, Olyaei A, Laraway B, Jordan BK, Dickinson SL, Golzarri-Arroyo L, et al. Bifidobacteriumlongum subsp. infantis EVC001 administration is associated with a significant reduction in the incidence of necrotizing enterocolitis in very low birth weight infants. J Pediatr. 2022;244:64–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Frese SA, Hutton AA, Contreras LN, Shaw CA, Palumbo MC, Casaburi G, et al. Persistence of supplemented Bifidobacterium longum subsp. infantis EVC001 in breastfed infants. mSphere 2017;2:e00501–17.

Article  PubMed  PubMed Central  Google Scholar 

Kliegman RM, Walsh MC. Neonatal necrotizing enterocolitis: pathogenesis, classification, and spectrum of illness. Curr Probl Pediatr. 1987;17:213–88.

CAS  PubMed  Google Scholar 

Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg. 1978;187:1–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sharif S, Meader N, Oddie SJ, Rojas-Reyes MX, McGuire W. Probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants. Cochrane Database Syst Rev. 2020;10:CD005496.

PubMed  Google Scholar 

Wang Y, Florez ID, Morgan RL, Foroutan F, Chang Y, Crandon HN, et al. Probiotics, prebiotics, lactoferrin, and combination products for prevention of mortality and morbidity in preterm infants: a systematic review and network meta-analysis [published correction appears in JAMA Pediatr. 2024 Jan 1;178(1):99]. JAMA Pediatr. 2023;177:1158–67.

Article  PubMed  PubMed Central  Google Scholar 

Wang H, Meng X, Xing S, Guo B, Chen Y, Pan YQ. Probiotics to prevent necrotizing enterocolitis and reduce mortality in neonates: a meta-analysis. Med (Baltim). 2023;102:e32932.

Article  CAS  Google Scholar 

Sun J, Marwah G, Westgarth M, Buys N, Ellwood D, Gray PH. Effects of probiotics on necrotizing enterocolitis, sepsis, intraventricular hemorrhage, mortality, length of hospital stay, and weight gain in very preterm infants: a meta-analysis. Adv Nutr. 2017;8:749–63.

Article  PubMed 

留言 (0)

沒有登入
gif